Literature DB >> 7202259

Biochemical correlates of morphologic differentiation in human breast cancer.

J S Silva, C E Cox, S A Wells, D Paull, W G Dilley, K S McCarty, B F Fetter, L C Glaubitz, K S McCarty.   

Abstract

In 115 breast carcinoma tissues, histologica grade and cell cytosol concentrations of estrogen receptor (ER) and progesterone receptor (PR) and two breast cyst fluid proteins (gross cystic disease fluid protein [GCDFP-15] and nonreceptor progesterone-binding protein [PBP]) were deterMined. Higher levels (expressed as femtomoles per milligram of protein) of ER (128 +/- 28 versus 11 +/- 1, P less than 0.001) and PR (82 +/- 16 versus 3 +/- 1, P less than 0.001) were found in grade 1 (well-differentiated) carcinomas as compared with grade 3 (poorly differentiated) carcinomas. Similarly, higher concentrations (expressed as nanograms per milligram of cytosol protein) of GCDFP-15 (2110 +/- 840 versus 210 +/- 40, p less than 0.001) and PBP (4920 +/- 1200 versus 370 +/- 60, P less than 0.001) were found in grade 1 as compared with grade 3 carcinomas. Tumor cytosols that contained low levels of both cyst proteins (less than 225 ng/mg GCDFP-15 and less than 750 ng/mg PBP) had a high incidence of grade 3 (35 of 46, 78%) or grade 2 (15 of 46, 33%) histologic findings and had a high incidence of receptor-negative specimens (27 of 52, 52%). Based on these cutoff levels, grade 2 lesions were subdivided into a "high" cyst protein group, which had ER and PR levels similar to grade 1 tumors (93.1 +/- 26.7 for ER and 84.7 +/- 32.4 for PR, P greater than 0.3), and a "low" group, which had receptor values similar to grade 3 carcinomas (14.1 +/- 5.3 for ER and 9.1 +/- 5.2 for PR, P less than 0.3). Although the mean cytosol content of carcinoembryonic antigen (CEA) was significantly higher in malignant tissues (125 +/- 27 ng/mg cytosol protein) than in benign tissues (4.8 +/- 1 ng/mg cytosol protein), the CEA content was not significantly different between grades 1 and 3 tumors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7202259

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Transferrin receptor is inversely correlated with estrogen receptor in breast cancer.

Authors:  S E Tonik; J E Shindelman; H H Sussman
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

2.  Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?

Authors:  J A Søreide; O A Lea; S Kvinnsland
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

3.  Expression and prognostic significance of apolipoprotein D in breast cancer.

Authors:  I Díez-Itza; F Vizoso; A M Merino; L M Sánchez; J Tolivia; J Fernández; A Ruibal; C López-Otín
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

4.  Is apocrine differentiation in breast carcinoma of prognostic significance?

Authors:  N J Bundred; R A Walker; D Everington; G K White; H J Stewart; W R Miller
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

Review 5.  No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis.

Authors:  Xing-Ling Qi; Jun Yao; Yong Zhang
Journal:  BMC Med Genet       Date:  2017-10-30       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.